Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,099 public trials 2,041 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19

NCT04452604

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia, Hematologic Diseases, +13 more
Locations: Chu Amiens Amiens, France

CHU ANGERS - Maladies du sang Angers, France

Ch Avignon Avignon, France

CH de la Côte Basque - Hématologie Bayonne, France

View all 27 locations

View Trial Details

Completed

A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT03650491

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

University of Colorado Cancer Center Aurora, Colorado, United States

Winship Cancer Institute, Emory University Atlanta, Georgia, United States

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Completed

Vinorelbine for Recurrent ACLC

NCT03397953

Conditions: Anaplastic Large Cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
Locations: Shanghai Children's Medical Center Shanghai, Shanghai Municipality, China

View Trial Details

Completed

A Study of PLX2853 in Advanced Malignancies.

NCT03297424

Conditions: Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +36 more
Locations: Honor Health Scottsdale, Arizona, United States

Sylvester Comprehensive Cancer Center / University of Miami Miller School of Medicine Miami, Florida, United States

Columbia University Medical Center New York, United States

South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States

View Trial Details

Completed

informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia

NCT02582879

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations: Clearview Cancer Institute Huntsville, Alabama, United States

Northwest Alabama Cancer Center, PC Muscle Shoals, Alabama, United States

Arizona Oncology Associates, PC - HAL Glendale, Arizona, United States

Arizona Oncology Associates, PC - HAL Phoenix, Arizona, United States

View all 192 locations

View Trial Details

Completed

Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT)

NCT01827579

Conditions: Haematological Malignancies, Hematologic Diseases, Hemic and Lymphatic Diseases, +17 more
Locations: University College London Hospital London, United Kingdom

Manchester Royal Infirmary Manchester, United Kingdom

View Trial Details

Completed

Telerehabilitation and Lymphoma Patients

NCT04822389

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: University Hospital Brno Brno, Czechia

View Trial Details

Completed

Subclinical Cardio-toxicities Evaluation With Strain Rate Echocardiography After Chemotherapy and/or Mediastinal Radiotherapy in Patient With Lymphoma

NCT03480087

Conditions: Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +18 more
Locations: SC Ematologia - AOU Città della salute e della Scienza di Torino Torino, Italy

View Trial Details

Completed

Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

NCT01005277

Conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, Adult Acute Promyelocytic Leukemia With PML-RARA, +21 more
Locations: Childrens Oncology Group Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

NCT03023046

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions